Fidelity International
SRPT icon

Fidelity International’s Sarepta Therapeutics SRPT Stock Holding History

Fidelity International’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-19,800
Closed -$1.48M – 1061
2021
Q1 		$1.48M Buy
19,800
+19,386
+4,683% +$1.79M ﹤0.01% 696
2020
Q4 		$70K Sell
414
-35,033
-99% -$5.19M ﹤0.01% 756
2020
Q3 		$4.98M Sell
35,447
-146,220
-80% -$22.2M 0.01% 536
2020
Q2 		$29.1M Buy
181,667
+42,935
+31% +$5.84M 0.04% 339
2020
Q1 		$13.6M Sell
138,732
-272,240
-66% -$31.1M 0.02% 408
2019
Q4 		$53M Sell
410,972
-1,843,960
-82% -$186M 0.07% 248
2019
Q3 		$170M Buy
2,254,932
+482,428
+27% +$57M 0.26% 102
2019
Q2 		$269M Buy
1,772,504
+542,533
+44% +$65.9M 0.41% 67
2019
Q1 		$147M Sell
1,229,971
-338,895
-22% -$43.6M 0.23% 125
2018
Q4 		$171M Sell
1,568,866
-224,835
-13% -$28.1M 0.3% 90
2018
Q3 		$290M Buy
1,793,701
+723,542
+68% +$98.9M 0.43% 56
2018
Q2 		$141M Buy
+1,070,159
New +$101M 0.21% 125

Other funds holding SRPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity International's SRPT Position: Q2 2021 in Review

Fidelity International sold out of Sarepta Therapeutics (SRPT) in Q2 2021, closing a stake of 19,800 shares — an estimated $1.48M sold.

Fidelity International first reported a position in SRPT in Q2 2018 and held it in 12 quarters. The position peaked at $290M in Q3 2018. 330 funds tracked by Wall St. Rank hold SRPT as of Q2 2021.

  • Fidelity International reported no remaining Sarepta Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Fidelity International sold 19,800 Sarepta Therapeutics shares in Q2 2021, an estimated $1.48M.
  • Fidelity International first reported a position in Sarepta Therapeutics in Q2 2018 and held it in 12 quarters.
  • Fidelity International's Sarepta Therapeutics position peaked at $290M in Q3 2018.
  • 330 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2021.

Based on Fidelity International's 13F filing for Q2 2021, filed 13 Aug 2021.